Evidence map›Paper›PMID 36244759›Full record

ArticleEnvironmental health and preventive medicine2022

Genetic and immune changes in Tibetan high-altitude populations contribute to biological adaptation to hypoxia.

Jun Bai, Lijuan Li, Yanhong Li, Liansheng Zhang

Open access · goldAbstract read
In one paragraph

Article in Environmental health and preventive medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Roles of the Altitude-Adapted Immune Microenvironment in Pulmonary Vascular Remodeling in High-Altitude Pulmonary Hypertension: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jun BaiInstitute of Hematology, Lanzhou University Second Hospital.
Lijuan LiInstitute of Hematology, Lanzhou University Second Hospital.
Yanhong LiInstitute of Hematology, Lanzhou University Second Hospital.
Liansheng ZhangInstitute of Hematology, Lanzhou University Second Hospital.
Lanzhou University · CNLanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTibetans have lived at very high altitudes for thousands of years, and have a distinctive suite of physiological traits that enable them to tolerate environmental hypoxia. Expanding awareness and knowledge of the differences in hematology, hypoxia-associated genes, immune system of people living at different altitudes and from different ethnic groups may provide evidence for the prevention of mountain sickness.

methodNinety-five Han people at mid-altitude, ninety-five Tibetan people at high-altitude and ninety-eight Han people at high-altitude were recruited. Red blood cell parameters, immune cells, the contents of cytokines, hypoxia-associated gene single nucleotide polymorphisms (SNPs) were measured.

resultsThe values of Hematocrit (HCT), Mean cell volume (MCV) and Mean cell hemoglobin (MCH) in red blood cell, immune cell CD19

conclusionsThese results indicated that biological adaption to hypoxia at high altitude might have been mediated by changes in immune cells, cytokines, and hypoxia-associated genes during the evolutionary history of Tibetan populations. Furthermore, different responses to high altitude were observed in different ethnic groups, which may provide a useful knowledge to improve the protection of high-altitude populations from mountain sickness.

Indexed as

AltitudeAltitude SicknessAdaptation, BiologicalBasic Helix-Loop-Helix ProteinsCD8-Positive T-LymphocytesChemokine CCL4Erb-b2 Receptor Tyrosine KinasesHemoglobinsHumansHypoxiaHypoxia-Inducible Factor 1Hypoxia-Inducible Factor-Proline DioxygenasesInterleukin-8Polymorphism, Single NucleotideReceptors, Tumor Necrosis Factor, Type IIThrombomodulinBasic Helix-Loop-Helix ProteinsChemokine CCL4Erb-b2 Receptor Tyrosine KinasesHemoglobinsHypoxia-Inducible Factor 1Hypoxia-Inducible Factor-Proline DioxygenasesInterleukin-8Receptors, Tumor Necrosis Factor, Type IIThrombomodulinGeneticsHigh altitudeHypoxiaImmuneTibetan

Identifiers

PMID36244759
PMCPMC9640738
OpenAlexW4306669196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.